Interaction of CD31 with a heterophilic counterreceptor involved in downregulation of human T cell responses

doi:10.1084/jem.184.1.41

This Article

	Full Text (PDF, 1221K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Prager, E.
	Articles by Stockinger, H.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Prager, E.
	Articles by Stockinger, H.


Social Bookmarking

	What's this?

ARTICLES

Interaction of CD31 with a heterophilic counterreceptor involved in downregulation of human T cell responses

E Prager, R Sunder-Plassmann, C Hansmann, C Koch, W Holter, W Knapp and H Stockinger
Institute of Immunology, Vienna International Research Cooperation Center at Sandoz Forschunginstitut, University of Vienna, Austria.

CD31 is a 130-kD glycoprotein of the immunoglobulin (Ig) superfamily expressed on the surface of endothelial cells, platelets, and several leukocyte subsets. Previous reports indicated that CD31 can mediate intercellular adhesion via both homophilic and heterophilic interaction mechanisms. Using a soluble recombinant CD31-Ig fusion protein (CD31 receptor globulin [Rg]), we demonstrate here that human CD31- T lymphocytes and CD4+CD31- T cell clones express a heterophilic CD31 ligand that is upregulated 18 h after activation. Interaction of CD31Rg with CD31- T helper cell (Th) clones was divalent cation independent but could be blocked by heparin, thus indicating that the CD31 counterreceptor on T cells can be distinguished from the ligands identified on other cell types. Moreover, a single chain protein of 120 kD was precipitated by CD31Rg from the lysates of CD31- Th clones. CD31Rg completely downregulated the proliferative response and cytokine production (interleukin-4, interferon-gamma, and tumor necrosis factor- alpha) of CD31- Th clones when the cells were maximally stimulated via immobilized CD3 monoclonal antibody. These results suggest that interaction of CD31 with a heterophilic counterreceptor on T lymphocytes can interfere with a positive regulatory pathway of T cell activation, or directly signal T cells to downregulate immune function.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Gandhi, N. S, Mancera, R. L (2009). Free energy calculations of glycosaminoglycan-protein interactions. Glycobiology 19: 1103-1115 [Abstract] [Full Text]
Kohler, S., Thiel, A. (2009). Life after the thymus: CD31+ and CD31- human naive CD4+ T-cell subsets. Blood 113: 769-774 [Abstract] [Full Text]
Groyer, E., Nicoletti, A., Ait-Oufella, H., Khallou-Laschet, J., Varthaman, A., Gaston, A.-T., Thaunat, O., Kaveri, S. V., Blatny, R., Stockinger, H., Mallat, Z., Caligiuri, G. (2007). Atheroprotective Effect of CD31 Receptor Globulin Through Enrichment of Circulating Regulatory T-Cells. J Am Coll Cardiol 50: 344-350 [Abstract] [Full Text]
Caligiuri, G., Rossignol, P., Julia, P., Groyer, E., Mouradian, D., Urbain, D., Misra, N., Ollivier, V., Sapoval, M., Boutouyrie, P., Kaveri, S. V., Nicoletti, A., Lafont, A. (2006). Reduced Immunoregulatory CD31+ T Cells in Patients With Atherosclerotic Abdominal Aortic Aneurysm. Arterioscler. Thromb. Vasc. Bio. 26: 618-623 [Abstract] [Full Text]
Caligiuri, G., Groyer, E., Khallou-Laschet, J., Zen, A. A. H., Sainz, J., Urbain, D., Gaston, A.-T., Lemitre, M., Nicoletti, A., Lafont, A. (2005). Reduced Immunoregulatory CD31+ T Cells in the Blood of Atherosclerotic Mice With Plaque Thrombosis. Arterioscler. Thromb. Vasc. Bio. 25: 1659-1664 [Abstract] [Full Text]
O'Brien, C. D., Cao, G., Makrigiannakis, A., DeLisser, H. M. (2004). Role of immunoreceptor tyrosine-based inhibitory motifs of PECAM-1 in PECAM-1-dependent cell migration. Am. J. Physiol. Cell Physiol. 287: C1103-C1113 [Abstract] [Full Text]
Tenca, C., Merlo, A., Zarcone, D., Saverino, D., Bruno, S., De Santanna, A., Ramarli, D., Fabbi, M., Pesce, C., Deaglio, S., Ciccone, E., Malavasi, F., Grossi, C. E. (2003). Death of T cell precursors in the human thymus: a role for CD38. Int Immunol 15: 1105-1116 [Abstract] [Full Text]
Righi, L., Deaglio, S., Pecchioni, C., Gregorini, A., Horenstein, A. L., Bussolati, G., Sapino, A., Malavasi, F. (2003). Role of CD31/Platelet Endothelial Cell Adhesion Molecule-1 Expression in in Vitro and in Vivo Growth and Differentiation of Human Breast Cancer Cells. Am. J. Pathol. 162: 1163-1174 [Abstract] [Full Text]
Prager, E., Staffler, G., Majdic, O., Saemann, M. D., Godar, S., Zlabinger, G. J., Stockinger, H. (2001). Induction of Hyporesponsiveness and Impaired T Lymphocyte Activation by the CD31 Receptor:Ligand Pathway in T Cells. J. Immunol. 166: 2364-2371 [Abstract] [Full Text]
Wong, C. W.Y., Wiedle, G., Ballestrem, C., Wehrle-Haller, B., Etteldorf, S., Bruckner, M., Engelhardt, B., Gisler, R. H., Imhof, B. A. (2000). PECAM-1/CD31 Trans-homophilic Binding at the Intercellular Junctions Is Independent of Its Cytoplasmic Domain; Evidence for Heterophilic Interaction with Integrin alpha vbeta 3 in Cis. Mol. Biol. Cell 11: 3109-3121 [Abstract] [Full Text]
Mahooti, S., Graesser, D., Patil, S., Newman, P., Duncan, G., Mak, T., Madri, J. A. (2000). PECAM-1 (CD31) Expression Modulates Bleeding Time in Vivo. Am. J. Pathol. 157: 75-81 [Abstract] [Full Text]
Thompson, R. D., Wakelin, M. W., Larbi, K. Y., Dewar, A., Asimakopoulos, G., Horton, M. A., Nakada, M. T., Nourshargh, S. (2000). Divergent Effects of Platelet-Endothelial Cell Adhesion Molecule-1 and {beta}3 Integrin Blockade on Leukocyte Transmigration In Vivo. J. Immunol. 165: 426-434 [Abstract] [Full Text]
Johnson-Leger, C, Aurrand-Lions, M, Imhof, B. (2000). The parting of the endothelium: miracle, or simply a junctional affair?. J. Cell Sci. 113: 921-933 [Abstract]
Nakada, M. T., Amin, K., Christofidou-Solomidou, M., O'Brien, C. D., Sun, J., Gurubhagavatula, I., Heavner, G. A., Taylor, A. H., Paddock, C., Sun, Q.-H., Zehnder, J. L., Newman, P. J., Albelda, S. M., DeLisser, H. M. (2000). Antibodies Against the First Ig-Like Domain of Human Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) That Inhibit PECAM-1-Dependent Homophilic Adhesion Block In Vivo Neutrophil Recruitment. J. Immunol. 164: 452-462 [Abstract] [Full Text]
Chiba, R., Nakagawa, N., Kurasawa, K., Tanaka, Y., Saito, Y., Iwamoto, I. (1999). Ligation of CD31 (PECAM-1) on Endothelial Cells Increases Adhesive Function of alpha vbeta 3 Integrin and Enhances beta 1 Integrin-Mediated Adhesion of Eosinophils to Endothelial Cells. Blood 94: 1319-1329 [Abstract] [Full Text]
Koch, C., Staffler, G., Huttinger, R., Hilgert, I., Prager, E., Cerny, J., Steinlein, P., Majdic, O., Horejsi, V., Stockinger, H. (1999). T cell activation-associated epitopes of CD147 in regulation of the T cell response, and their definition by antibody affinity and antigen density. Int Immunol 11: 777-786 [Abstract] [Full Text]
Duncan, G. S., Andrew, D. P., Takimoto, H., Kaufman, S. A., Yoshida, H., Spellberg, J., Luis de la Pompa, J., Elia, A., Wakeham, A., Karan-Tamir, B., Muller, W. A., Senaldi, G., Zukowski, M. M., Mak, T. W. (1999). Genetic Evidence for Functional Redundancy of Platelet/Endothelial Cell Adhesion Molecule-1 (PECAM-1): CD31-Deficient Mice Reveal PECAM-1-Dependent and PECAM-1-Independent Functions. J. Immunol. 162: 3022-3030 [Abstract] [Full Text]
Bird, I., Taylor, V, Newton, J., Spragg, J., Simmons, D., Salmon, M, Buckley, C. (1999). Homophilic PECAM-1(CD31) interactions prevent endothelial cell apoptosis but do not support cell spreading or migration. J. Cell Sci. 112: 1989-1997 [Abstract]
Riesbeck, K., Billström, A., Tordsson, J., Brodin, T., Kristensson, K., Dohlsten, M. (1998). Endothelial Cells Expressing an Inflammatory Phenotype Are Lysed by Superantigen-Targeted Cytotoxic T Cells. CVI 5: 675-682 [Abstract] [Full Text]
Cao, M. Y., Huber, M., Beauchemin, N., Famiglietti, J., Albelda, S. M., Veillette, A. (1998). Regulation of Mouse PECAM-1 Tyrosine Phosphorylation by the Src and Csk Families of Protein-tyrosine Kinases. J. Biol. Chem. 273: 15765-15772 [Abstract] [Full Text]
Sun, Q.-H., Paddock, C., Visentin, G. P., Zukowski, M. M., Muller, W. A., Newman, P. J. (1998). Cell Surface Glycosaminoglycans Do Not Serve as Ligands for PECAM-1. PECAM-1 IS NOT A HEPARIN-BINDING PROTEIN. J. Biol. Chem. 273: 11483-11490 [Abstract] [Full Text]
Varon, D., Jackson, D. E., Shenkman, B., Dardik, R., Tamarin, I., Savion, N., Newman, P. J. (1998). Platelet/Endothelial Cell Adhesion Molecule-1 Serves as a Costimulatory Agonist Receptor That Modulates Integrin-Dependent Adhesion and Aggregation of Human Platelets. Blood 91: 500-507 [Abstract] [Full Text]
Deaglio, S., Morra, M., Mallone, R., Ausiello, C. M., Prager, E., Garbarino, G., Dianzani, U., Stockinger, H., Malavasi, F. (1998). Human CD38 (ADP-Ribosyl Cyclase) Is a Counter-Receptor of CD31, an Ig Superfamily Member. J. Immunol. 160: 395-402 [Abstract] [Full Text]
Famiglietti, J., Sun, J., DeLisser, H. M., Albelda, S. M. (1997). Tyrosine Residue in Exon 14 of the Cytoplasmic Domain of Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1/CD31) Regulates Ligand Binding Specificity. JCB 138: 1425-1435 [Abstract] [Full Text]
Newton, J. P., Buckley, C. D., Jones, E. Y., Simmons, D. L. (1997). Residues on Both Faces of the First Immunoglobulin Fold Contribute to Homophilic Binding Sites of PECAM-1/CD31. J. Biol. Chem. 272: 20555-20563 [Abstract] [Full Text]
Chen, Y., Schlegel, P. G., Tran, N., Thompson, D., Zehnder, J. L., Chao, N. J. (1997). Administration of a CD31-Derived Peptide Delays the Onset and Significantly Increases Survival From Lethal Graft-Versus-Host Disease. Blood 89: 1452-1268 [Abstract] [Full Text]
Cao, G., O'Brien, C. D., Zhou, Z., Sanders, S. M., Greenbaum, J. N., Makrigiannakis, A., DeLisser, H. M. (2002). Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration. Am. J. Physiol. Cell Physiol. 282: C1181-C1190 [Abstract] [Full Text]